Pricing Log in Create free account

Aspira Women's Health Inc. (AWHL) vs ENDRA Life Sciences Inc. (NDRA)

Aspira Women's Health Inc. and ENDRA Life Sciences Inc. are both Diagnostics & Research companies. ENDRA Life Sciences Inc. is the larger, with a market value of $7.7M against $2.4M — 3.1× the size. ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −117.1%) and the lower return on invested capital (−539.9% vs 0.00%). Across the 15 metrics below, Aspira Women's Health Inc. leads on 9 and ENDRA Life Sciences Inc. on 6.

Valuation

Metric AWHL NDRA Diagnostics & Research median
P/E n/m n/m 35.56
P/S 1.19 17.54 4.37
P/B n/m 0.99 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales 1.36 2.22 5.51
Earnings yield (106.09%) (133.33%) (1.89%)
Free cash flow yield (46.46%) (124.95%) (0.15%)

Profitability

Metric AWHL NDRA Diagnostics & Research median
Gross margin 58.78% 0.00% 50.89%
Operating margin (80.75%) 0.00% (8.57%)
Net margin (117.07%) 0.00% (6.37%)
Free cash flow margin (55.32%) 0.00% 0.00%
Return on equity 201.29% (152.04%) (2.92%)
Return on assets (213.58%) (110.08%) (6.71%)
Return on invested capital 0.00% (539.89%) 0.00%

Growth

Metric AWHL NDRA Diagnostics & Research median
Revenue growth (TTM) (8.00%) — 7.69%
EPS growth (last fiscal year) 60.22% 84.32% 25.92%
Revenue growth, 5-year CAGR 14.66% — 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AWHL NDRA Diagnostics & Research median
Debt to equity (0.27) 0.00 0.11
Current ratio 0.52 7.10 2.02
Net debt to EBITDA 0.00 0.14 0.70

Dividend

Metric AWHL NDRA Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric AWHL NDRA Diagnostics & Research median
Market cap 2.44m 7.65m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack